Industry Spotlight: Cell-El Therapeutics
About Cell-El Therapeutics
Cell-El has so far identified a panel of blood borne biomarkers that discriminate between children with ASD and typically developing (TD) , and plans to develop assays of the selected biomarkers to be used as ASD diagnostic tool.
The identified biomarkers will be used to identify children who may benefit from stem cell and/or other treatments.
Cell-El Therapeutic Clinical Trials for Autism
Cell-El is planning a clinical trial in which children with severe ASD will undergo SCT, accompanied by psychological and laboratory evaluations to assess the impact of the treatment on autistic behavior, the immune system and the potential correlation between them.